OGI: Organigram Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 216.43
Enterprise Value ($M) n/a
Book Value ($M) 257.82
Book Value / Share 2.73
Price / Book n/a
NCAV ($M) 119.10
NCAV / Share 1.26
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.87
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.45

Liquidity (mrq)
Quick Ratio 2.11
Current Ratio 4.28

Balance Sheet (mrq) ($M)
Current Assets 160.29
Assets 299.01
Liabilities 41.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 161.64
Operating Income -52.86
Net Income -248.60

Cash Flow Statement (mra) ($M)
Cash From Operations -38.78
Cash from Investing 4.94
Cash from Financing -0.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-25 13D/A BT DE Investments Inc. 29.90 84.55

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 2,995,284 8,446,817 35.46
2024-03-26 429,144 428,874 100.06
2024-03-25 309,775 309,477 100.10
2024-03-22 588,257 2,912,283 20.20

(click for more detail)

Similar Companies
NUVL – Nuvalent, Inc. NVAX – Novavax, Inc.
NXTC – NextCure, Inc. OLMA – Olema Pharmaceuticals, Inc.
OMGA – Omega Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io